Company Profile
Mycenax Biotech provides biopharmaceutical services and solutions for drug development and production in Taiwan. The company's services include program evaluation/confirmation, cell line development and construction, process development technology platforms, drug characterization analysis, establishment of testing methods, and PIC/S GMP drug production. It offers CDMO services, including integrated biologics development services, specialized modalities, manufacturing, and quality services
Bispecific antibody production, and NaxLeap, a transposon system. Its portfolio also includes PlasMX, a plasmid DNA manufacturing, differential scanning fluorimetry, antibody-drug conjugates, cell and gene therapy
Including allogeneic immune cell solutions, and ExoMX, a exosome manufacturing, and white papers, articles, and posters and flyers. Founded in 2001, the company is headquartered in Zhubei, Taiwan.